GOBBI, MARCO

GOBBI, MARCO  

100007 - Dipartimento di Medicina interna e specialità mediche  

Mostra records
Risultati 1 - 20 di 247 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autore(i) File
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis 1-gen-2018 Minetto, P.; Guolo, F.; Clavio, M.; Kunkl, A.; Colombo, N.; Carminati, E.; Giannoni, L.; Ballerini, F.; Lemoli, R. M.; Gobbi, M.; Miglino, M.
A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies. 1-gen-1992 Bolognesi, A; Tazzari, Pl; Tassi, C; Gromo, G; Gobbi, Marco; Stirpe, F.
A sensitive test for the detection of NK activity. Plasma clot clonogenic assay. 1-gen-1988 Dinota, A; Gobbi, Marco; Tazzari, Pl; Raspadori, D; Bontadini, A; Lauria, F; Foà, R; Tura, S.
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 1-gen-2007 Clavio, M.; Vignolo, L.; Albarello, A.; Varaldo, R.; Pierri, Ivana; Catania, G.; Balocco, M.; Michelis, G.; Miglino, Maurizio; Manna, A.; Balleari, E.; Carella, A. M.; Sessarego, Mario; VAN LINT, M. T.; Bacigalupo, A.; Gobbi, Marco
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience. 1-gen-2009 Olcese, F; Clavio, M; Rossi, E; Spriano, M; Ballerini, F; Canepa, L; Pierri, Ivana; Aquino, S; Varaldo, R; Manna, A; Secondo, V; Racchi, O; Balleari, E; Orcioni, Gf; Carella, Am; Ghio, Riccardo; Gobbi, Marco
Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes 1-gen-2015 Balleari, Enrico; Salvetti, C.; Del Corso, L.; Filiberti, R.; Bacigalupo, A.; Bellodi, A.; Beltrami, G.; Bergamaschi, M.; Berisso, G.; Calzamiglia, T.; Carella, A. M.; Cavalleri, M.; Da Col, A.; Favorini, S.; Forni, G. L.; Goretti, R.; Miglino, Maurizio; Mitscheuning, L.; Molinari, E.; Racchi, O.; Scudeletti, M.; Tassara, R.; Gobbi, Marco; Lemoli, ROBERTO MASSIMO; Clavio, M.
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 1-gen-2002 Miglino, Maurizio; Berisso, G; Grasso, R; Canepa, L; Verdiani, Simonetta; Clavio, M; Pierri, Ivana; Pietrasanta, D; Gatto, S; Varaldo, R; Ballerini, F; Verdiani, S; Casarino, L; Destefano, F; Sessarego, Mario; Dominietto, A; Raiola, Am; Bregante, S; DI GRAZIA, C; Gobbi, Marco; Bacigalupo, A.
[Allogeneic bone marrow transplantation in multiple myeloma]. 1-gen-1989 Bandini, G; Rosti, G; Cavo, M; Albertazzi, L; Rizzi, S; Motta, Mr; Gobbi, Marco; Tassi, C; Tazzari, Pl; Miggiano, C.
Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis 1-gen-2000 Damasio, E. E.; Clavio, M.; Masoudi, B.; Spriano, M.; Rossi, E.; Casciaro, S.; Cerri, R.; Cerri, R.; Risso, M.; Truini, M.; Gobbi, Marco
Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V? 2 T lymphocytes in non-Hodgkin lymphomas 1-gen-2014 Musso, A; Catellani, S; Canevali, P; Tavella, Sara; Venè, R; Boero, S; Pierri, I; Gobbi, Marco; Kunkl, A; Ravetti, Jl; Zocchi, Mr; Poggi, A.
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) grows in SCID-mice with the features of a CD30+ anaplastic large cell lymphoma and is sensitive to anti-CD30 immunotoxins 1-gen-1999 Tazzari, P. L.; DE TOTERO, D.; Bolognesi, A.; Testoni, N.; Pileri, S.; Roncella, S.; Reato, G.; Stein, H.; Gobbi, Marco; Stirpe, F.
An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells. 1-gen-1988 Tazzari, Pl; Barbieri, L; Gobbi, Marco; Dinota, A; Rizzi, S; Bontadini, A; Pession, A; Tura, S; Stirpe, F.
An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients. 1-gen-1989 Dinota, A; Barbieri, L; Gobbi, Marco; Tazzari, Pl; Rizzi, S; Bontadini, A; Bolognesi, A; Tura, S; Stirpe, F.
An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience. 1-gen-1987 Gobbi, Marco; Barbieri, L; Tazzari, Pl; Dinota, A; Bontadini, A; Rizzi, S; Pession, A; Stirpe, F; Tura, S.
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma. 1-gen-1993 Miglino, Maurizio; Pierri, Ivana; Canepa, L; Carrara, P; Celesti, L; Gobbi, Marco
Anaplastic large cell lymphoma Hodgkin's like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy 1-gen-1998 Zinzani, P. L.; Martelli, M.; Magagnoli, M.; Gobbi, Marco
Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients. 1-gen-1996 Clavio, M.; Rossi, E.; Truini, M.; Carrara, P.; Ravetti, J. L.; Spriano, M; Vimercati, A. R.; Gobbi, Marco
Anticytoskeleton autoantibodies and chronic graft versus host disease. 1-gen-1985 Gobbi, Marco; Tazzari, P; Tassinari, A; Bandini, G; Zauli, D; Crespi, C; Miserocchi, F; Tura, S.
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 1-gen-2009 Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco
APO866 activity in hematologic malignancies: a preclinical in vitro study. 1-gen-2009 Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio